Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouth Neoplasms | 5 | 2025 | 64 | 3.440 |
Why?
|
| Areca | 5 | 2025 | 5 | 3.150 |
Why?
|
| Nuts | 2 | 2025 | 3 | 1.710 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 303 | 1.280 |
Why?
|
| Measles | 3 | 2025 | 7 | 0.950 |
Why?
|
| Carcinoma, Verrucous | 1 | 2024 | 1 | 0.890 |
Why?
|
| Parasites | 2 | 2022 | 11 | 0.870 |
Why?
|
| Communicable Diseases | 1 | 2024 | 21 | 0.840 |
Why?
|
| Toxoplasma | 1 | 2022 | 33 | 0.710 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 6 | 0.650 |
Why?
|
| Radiotherapy | 1 | 2020 | 41 | 0.640 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 191 | 0.630 |
Why?
|
| Carcinoma | 1 | 2020 | 74 | 0.620 |
Why?
|
| Nasal Septum | 1 | 2019 | 3 | 0.600 |
Why?
|
| Nasal Obstruction | 1 | 2019 | 6 | 0.600 |
Why?
|
| Rhinoplasty | 1 | 2019 | 4 | 0.600 |
Why?
|
| Mosquito Vectors | 2 | 2026 | 10 | 0.480 |
Why?
|
| Micronesia | 3 | 2020 | 5 | 0.480 |
Why?
|
| Anopheles | 2 | 2026 | 12 | 0.480 |
Why?
|
| Immunization Programs | 2 | 2025 | 15 | 0.470 |
Why?
|
| Humans | 17 | 2026 | 28909 | 0.460 |
Why?
|
| Vaccines | 2 | 2025 | 35 | 0.450 |
Why?
|
| Immunization | 2 | 2025 | 121 | 0.450 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 686 | 0.430 |
Why?
|
| Measles Vaccine | 3 | 2025 | 4 | 0.410 |
Why?
|
| Lymphatic Metastasis | 2 | 2024 | 126 | 0.370 |
Why?
|
| Mastication | 2 | 2022 | 4 | 0.360 |
Why?
|
| Vaccination | 4 | 2025 | 194 | 0.350 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 480 | 0.350 |
Why?
|
| Immunization Schedule | 3 | 2025 | 13 | 0.350 |
Why?
|
| Measles virus | 2 | 2022 | 3 | 0.330 |
Why?
|
| Adult | 4 | 2025 | 8037 | 0.300 |
Why?
|
| Advisory Committees | 2 | 2025 | 33 | 0.290 |
Why?
|
| Young Adult | 3 | 2020 | 2841 | 0.280 |
Why?
|
| Protozoan Proteins | 2 | 2024 | 54 | 0.240 |
Why?
|
| Mosquito Control | 1 | 2025 | 2 | 0.240 |
Why?
|
| Risk Factors | 2 | 2022 | 2129 | 0.240 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 1002 | 0.240 |
Why?
|
| Health Literacy | 1 | 2025 | 34 | 0.230 |
Why?
|
| Feeding Behavior | 1 | 2026 | 104 | 0.220 |
Why?
|
| Biosurveillance | 1 | 2024 | 1 | 0.220 |
Why?
|
| Seroepidemiologic Studies | 1 | 2024 | 10 | 0.220 |
Why?
|
| Apicomplexa | 1 | 2024 | 4 | 0.210 |
Why?
|
| Middle Aged | 3 | 2020 | 7419 | 0.210 |
Why?
|
| Malaria, Falciparum | 2 | 2026 | 7 | 0.210 |
Why?
|
| Female | 7 | 2026 | 15650 | 0.210 |
Why?
|
| Protein Kinases | 1 | 2024 | 155 | 0.200 |
Why?
|
| Proteomics | 1 | 2024 | 197 | 0.190 |
Why?
|
| Nucleotides, Cyclic | 1 | 2022 | 4 | 0.180 |
Why?
|
| Malaria Vaccines | 2 | 2025 | 2 | 0.180 |
Why?
|
| Malaria | 2 | 2026 | 18 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 347 | 0.180 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2022 | 19 | 0.180 |
Why?
|
| Cyclic GMP | 1 | 2022 | 29 | 0.180 |
Why?
|
| Cyclic AMP | 1 | 2022 | 96 | 0.180 |
Why?
|
| Zinc Oxide | 1 | 2021 | 3 | 0.180 |
Why?
|
| World Health Organization | 3 | 2025 | 13 | 0.180 |
Why?
|
| Male | 4 | 2020 | 13947 | 0.170 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 121 | 0.160 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 16 | 0.160 |
Why?
|
| Medically Uninsured | 1 | 2020 | 31 | 0.160 |
Why?
|
| Zambia | 3 | 2026 | 5 | 0.160 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 236 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2020 | 103 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 226 | 0.160 |
Why?
|
| Binge Drinking | 1 | 2019 | 13 | 0.150 |
Why?
|
| Survival Rate | 1 | 2020 | 432 | 0.150 |
Why?
|
| Asymptomatic Infections | 1 | 2019 | 1 | 0.150 |
Why?
|
| Disease Reservoirs | 1 | 2019 | 6 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 36 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 14 | 0.150 |
Why?
|
| Tobacco Use | 1 | 2020 | 103 | 0.150 |
Why?
|
| Animals | 5 | 2026 | 10707 | 0.150 |
Why?
|
| Saliva | 1 | 2019 | 96 | 0.140 |
Why?
|
| Health Behavior | 1 | 2019 | 159 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 85 | 0.140 |
Why?
|
| Prevalence | 1 | 2019 | 518 | 0.140 |
Why?
|
| Disease Eradication | 1 | 2017 | 9 | 0.130 |
Why?
|
| Global Health | 1 | 2017 | 54 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 536 | 0.130 |
Why?
|
| Adolescent | 2 | 2020 | 3198 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2638 | 0.100 |
Why?
|
| Aged | 1 | 2019 | 5604 | 0.080 |
Why?
|
| Infant | 2 | 2025 | 1026 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2026 | 19 | 0.060 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2025 | 1 | 0.060 |
Why?
|
| Seasons | 1 | 2025 | 94 | 0.060 |
Why?
|
| Vaccination Coverage | 1 | 2025 | 13 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2025 | 52 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 429 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2024 | 151 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 109 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2024 | 585 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 80 | 0.050 |
Why?
|
| Optogenetics | 1 | 2021 | 8 | 0.040 |
Why?
|
| Crystallization | 1 | 2021 | 50 | 0.040 |
Why?
|
| Surface Properties | 1 | 2021 | 134 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 149 | 0.040 |
Why?
|
| Parasitemia | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cameroon | 1 | 2019 | 2 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 25 | 0.040 |
Why?
|
| Africa | 1 | 2016 | 18 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 782 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 996 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 469 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2292 | 0.020 |
Why?
|